Suppr超能文献

阿育吠陀药物斯瓦纳·巴斯马(金巴斯马)的血液相容性研究。

Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.

作者信息

Paul Willi, Sharma Chandra Prakash

机构信息

Division of Biosurface Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India.

出版信息

Int J Ayurveda Res. 2011 Jan;2(1):14-22. doi: 10.4103/0974-7788.83183.

Abstract

Swarna bhasma (gold bhasma) preparations are widely utilized as therapeutic agents. However, in vitro biological evaluations of bhasma preparations are needed along with the physicochemical characterization for present day standardization of metallic bhasma preparations to meet the criteria that supports its use. Therefore, an attempt has been made to evaluate the protein adsorption, blood compatibility and complement activation potential of two batches of Swarna bhasma preparation, along with its physicochemical characterization. The particle size, morphology, elemental analysis, and in vitro cytotoxicity were evaluated initially. Red blood cell hemolysis, aggregation studies with blood cells, protein adsorption, complement C3 adsorption, platelet activation and tight junction permeability in Caco-2 cell line were investigated. The Swarna bhasma preparations with a crystallite size of 28-35 nm did not induce any blood cell aggregation or protein adsorption. Activation potential of these preparations towards complement system or platelets was negligible. These particles were also non-cytotoxic. Swarna bhasma particles opened the tight junctions in Caco-2 cell experiments. The results suggest the application of Swarna bhasma preparations as a therapeutic agent in clinical medicine from the biological safety point of view.

摘要

斯瓦纳巴斯马(金巴斯马)制剂被广泛用作治疗剂。然而,为了满足支持其使用的标准,除了对金属巴斯马制剂进行物理化学表征外,还需要对巴斯马制剂进行体外生物学评估。因此,人们尝试对两批斯瓦纳巴斯马制剂的蛋白质吸附、血液相容性和补体激活潜力进行评估,并对其进行物理化学表征。首先评估了粒径、形态、元素分析和体外细胞毒性。研究了红细胞溶血、血细胞聚集、蛋白质吸附、补体C3吸附、血小板活化以及Caco-2细胞系中的紧密连接通透性。微晶尺寸为28-35nm的斯瓦纳巴斯马制剂未诱导任何血细胞聚集或蛋白质吸附。这些制剂对补体系统或血小板的激活潜力可忽略不计。这些颗粒也无细胞毒性。在Caco-2细胞实验中,斯瓦纳巴斯马颗粒打开了紧密连接。从生物安全性角度来看,结果表明斯瓦纳巴斯马制剂可作为治疗剂应用于临床医学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de82/3157103/b50db85280fd/IJAR-2-14-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验